Gabrielle S Kupferman
7PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 08, 2025
Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials.Avital M Miller, Adina H Passy, Alexander D Sherry
|Dec 10, 2024
Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study.Troy J Kleber, Alexander D Sherry, Andrew J Arifin
|Sep 30, 2024
Evidenced-Based Prior for Estimating the Treatment Effect of Phase III Randomized Trials in Oncology.Alexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman
|Aug 30, 2024
Increasing Power in Phase III Oncology Trials With Multivariable Regression: An Empirical Assessment of 535 Primary End Point Analyses.Alexander D Sherry, Adina H Passy, Zachary R McCaw
|Aug 14, 2024
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials.Alexander D Sherry, Timothy A Lin, Zachary R McCaw
Pageof 2
Frequent Collaborators
7 joint publications
Alexander D Sherry
7 joint publications
Ethan B Ludmir
7 joint publications
Ramez Kouzy
7 joint publications
Timothy A Lin
7 joint publications
Pavlos Msaouel
6 joint publications
Avital M Miller
5 joint publications
Esther J Beck
5 joint publications
Joseph Abi Jaoude
5 joint publications
Adina H Passy
5 joint publications
Zachary R McCaw
